Anixa Biosciences CEO Amit Kumar discusses the biotech’s plans for advancing a breast cancer vaccine in 2025. The cancer ...
I’m sharing this story now, more than eight years after her diagnosis, because a notorious vaccine skeptic may soon lead the ...
Long before mRNA vaccines captured global attention during the COVID-19 pandemic, researchers were already exploring their ...
Russia claims a breakthrough in cancer treatment with a personalized mRNA vaccine, designed to train the immune system to ...
HPV can cause a variety of cancers, including cervical. New mortality data for women under 25 point to the success of the HPV ...
Nationally, the average uptake for boys is 78.6% and 83.2% for girls. The HPV vaccine was introduced for girls in 2008 to ...
New research published in the New England Journal of Medicine has shown a single dose of the influenza vaccine is sufficient ...
Trial remains on track for completion and data readout in the second half of 2025COPENHAGEN, Denmark, January 15, 2025 - Evaxion Biotech A/S ...
Discover how the HPV vaccine is changing cancer prevention for both men and women with remarkable protection rates.
Delray Beach, FL, Jan. 14, 2025 (GLOBE NEWSWIRE) -- The global cancer vaccines market, valued at US$10.23 billion in 2023, is forecasted to grow at a robust CAGR of 8.6%, reaching US$10.61 billion ...
According to Dr. Sanjay Wazir, an expert at the Motherhood Hospital Gurgaon, "The HPV vaccine is crucial for boys and men for ...
Evaxion Biotech A/S (EVAX), a clinical-stage TechBio company specializing in AI-driven vaccines, has announced the completion of ...